| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:245-254.)
© 2007 American Heart Association, Inc.
Molecular Cardiology |
Induces Endothelial Dysfunction in Leprdb Mice
From the Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Tex (X.G., A.P., X.X., N.T.-S., S.C., C.Z.); and Department of Physiology, Louisiana State University Health Sciences Center, New Orleans (S.B., B.J.P., W.M.C.).
Correspondence to Cuihua Zhang, MD, PhD, Mechael E. DeBakey Institute, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843-4466. E-mail czhang{at}cvm.tamu.edu
Received July 9, 2006; accepted November 2, 2006.
Background We hypothesized that the inflammatory cytokine tumor necrosis factor-
(TNF) produces endothelial dysfunction in type 2 diabetes.
Methods and Results In m Leprdb control mice, sodium nitroprusside and acetylcholine induced dose-dependent vasodilation, and dilation to acetylcholine was blocked by the NO synthase inhibitor NG-monomethyl-L-arginine. In type 2 diabetic (Leprdb) mice, acetylcholine- or flow-induced dilation was blunted compared with m Leprdb, but sodium nitroprusside produced comparable dilation. In Leprdb mice null for TNF (dbTNF/dbTNF), dilation to acetylcholine or flow was greater than in diabetic Leprdb mice and comparable to that in controls. Plasma concentration of TNF was significantly increased in Leprdb versus m Leprdb mice. Real-time polymerase chain reaction and Western blotting showed that mRNA and protein expression of TNF and nuclear factor-
B were higher in Leprdb mice than in controls. Administration of anti-TNF or soluble receptor of advanced glycation end products attenuated nuclear factor-
B and TNF expression in the Leprdb mice. Immunostaining results show that TNF in mouse heart is localized predominantly in vascular smooth muscle cells rather than in endothelial cells and macrophages. Superoxide generation was elevated in vessels from Leprdb mice versus controls. Administration of the superoxide scavenger TEMPOL, NAD(P)H oxidase inhibitor (apocynin), or anti-TNF restored endothelium-dependent dilation in Leprdb mice. NAD(P)H oxidase activity, protein expression of nitrotyrosine, and hydrogen peroxide production were increased in Leprdb mice (compared with controls), but these variables were restored to control levels by anti-TNF.
Conclusion Advanced glycation end products/receptor of advanced glycation end products and nuclear factor-
B signaling play pivotal roles in TNF expression through an increase in circulating and/or local vascular TNF production in the Leprdb mouse with type 2 diabetes. Increases in TNF expression induce activation of NAD(P)H oxidase and production of reactive oxidative species, leading to endothelial dysfunction in type 2 diabetes.
This article has been cited by other articles:
![]() |
J. Yang, Y. Park, H. Zhang, X. Gao, E. Wilson, W. Zimmer, L. Abbott, and C. Zhang Role of MCP-1 in tumor necrosis factor-{alpha}-induced endothelial dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1208 - H1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Bagi Mechanisms of coronary microvascular adaptation to obesity Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R556 - R567. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Kang, R. A. Reyes, and J. M. Muller-Delp Aging impairs flow-induced dilation in coronary arterioles: role of NO and H2O2 Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1087 - H1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, J. Zhang, Z. Ungvari, and C. Zhang Resveratrol Improves Endothelial Function: Role of TNF{alpha} and Vascular Oxidative Stress Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1164 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar, N. Labinskyy, J. T. Pinto, P. Ballabh, H. Zhang, G. Losonczy, K. Pearson, R. de Cabo, P. Pacher, C. Zhang, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H13 - H20. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, Y. Park, H. Zhang, X. Xu, G. A. Laine, K. C. Dellsperger, and C. Zhang Feed-forward signaling of TNF-{alpha} and NF-{kappa}B via IKK-{beta} pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1850 - H1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Labinskyy, P. Mukhopadhyay, J. Toth, G. Szalai, M. Veres, G. Losonczy, J. T. Pinto, P. Pacher, P. Ballabh, A. Podlutsky, et al. Longevity is associated with increased vascular resistance to high glucose-induced oxidative stress and inflammatory gene expression in Peromyscus leucopus Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H946 - H956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arita, Y. Hata, S. Nakao, T. Kita, M. Miura, S. Kawahara, S. Zandi, L. Almulki, F. Tayyari, H. Shimokawa, et al. Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage Diabetes, January 1, 2009; 58(1): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. N. Duran The double-edge sword of TNF-{alpha} in ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2221 - H2222. [Full Text] [PDF] |
||||
![]() |
Y. Park, S. Capobianco, X. Gao, J. R. Falck, K. C. Dellsperger, and C. Zhang Role of EDHF in type 2 diabetes-induced endothelial dysfunction Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1982 - H1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, H. Zhang, A. M. Schmidt, and C. Zhang AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H491 - H498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar and Z. Ungvari Endothelial dysfunction and vascular inflammation in Type 2 diabetes: interaction of AGE/RAGE and TNF-{alpha} signaling Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H475 - H476. [Full Text] [PDF] |
||||
![]() |
M. Tesauro, F. Schinzari, V. Rovella, D. Melina, N. Mores, A. Barini, M. Mettimano, D. Lauro, M. Iantorno, M. J. Quon, et al. Tumor Necrosis Factor-{alpha} Antagonism Improves Vasodilation During Hyperinsulinemia in Metabolic Syndrome Diabetes Care, July 1, 2008; 31(7): 1439 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Belmadani, D. I. Palen, R. A. Gonzalez-Villalobos, H. A. Boulares, and K. Matrougui Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice Diabetes, June 1, 2008; 57(6): 1629 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jebelovszki, C. Kiraly, N. Erdei, A. Feher, E. T. Pasztor, I. Rutkai, T. Forster, I. Edes, A. Koller, and Z. Bagi High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2558 - H2564. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |